- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02296086
MobiChina - A Prospective Multicenter Cohort Study
A Prospective Multicenter Cohort Study to Evaluate the Effect of Early Mobilization of Patients After Hip Fracture Fixation on Functional Outcomes in the Chinese Population
Study Overview
Status
Conditions
Detailed Description
The primary objective of this prospective observational cohort study is to assess the difference in functionality between Group I and II (see mobilization regimens for the two groups above) at 6 weeks using the modified Barthel Index in the Chinese population.
The allocation of patients to the two groups will be performed on a clinic level: 50% of patients will be recruited by study sites in Group I (early mobilization). The other 50% of patients will be recruited by study sites in Group II. The sites are carefully selected after evaluating their standard procedures of mobilizing elderly patients after hip fractures. This process is documented using formal site selection questionnaires.
The modified Barthel Index is estimated at 75 points for Group II and at 85 points for Group I.
Patients aged 65 years and older with unstable intertrochanteric fractures (AO 31 A2 or A3) treated with an intramedullary nail will be included in this study.
The study visits will be defined as preoperative, surgery, discharge, 6 (± 2) weeks and 12 (± 2) weeks follow-up (FU) visits. Furthermore, there will be a telephone contact 12 months (± 1 month) postsurgery.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Beijing, China
- DCN Hospital
-
Chengdu, China
- West China Hospital of Sichuan University
-
Kunming, China
- Yunnan Second People Hospital
-
Nantong, China
- Nantong University 1st Affiliated Hospital
-
Shanghai, China
- Shanghai Sixth People Hospital
-
Shenzhen, China
- The University of Hong Kong-Shenzhen Hospital
-
Xi'an, China
- Hong Hui Hospital
-
-
Beijing
-
Beijing, Beijing, China
- JiShuiTan Hopsital
-
-
Hebei
-
Hebei, Hebei, China
- 3th Hospital of Hebei Medical University of Hebei
-
-
-
-
-
Hong Kong, Hong Kong
- Queen Elisabeth Hospital
-
-
Pokfulam
-
Hong Kong, Pokfulam, Hong Kong
- Queen Mary Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 65 and older
- Diagnosis of an unstable intertrochanteric fractures (AO 31- A2 or A3) treated with an intramedullary nail
- Ability to walk independently or with a walking aid prior to injury
- Informed consent obtained, i.e.: Ability of the patient to understand the content of the patient information / Informed Consent Form and signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved written informed consent
Exclusion Criteria:
- Severe dementia
- Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
- Prisoner
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group I
Study sites in which patients perform early mobilization as per local standard of care, which is as follows:
|
|
Group II
Study sites in which patients start walking (i.e.
partial weight bearing, walking aids allowed) more than 7 days after surgery as per local standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Barthel Index
Time Frame: 6 weeks postoperative
|
Investigator completed score
|
6 weeks postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Barthel Index
Time Frame: Baseline
|
Modified Barthel Index is retrospectively assessed for the pre-injury status using an investigator completed score
|
Baseline
|
|
Modified Barthel Index
Time Frame: 12 weeks postoperative
|
Investigator completed score
|
12 weeks postoperative
|
|
Immobilization-related adverse events
Time Frame: From surgery to 1 year follow-up
|
Immobilization-related adverse events:
|
From surgery to 1 year follow-up
|
|
Fixation failures
Time Frame: From surgery up to 1 year follow-up
|
As assessed by the local investigator
|
From surgery up to 1 year follow-up
|
|
Any other adverse events
Time Frame: From surgery up to 1 year follow-up
|
From surgery up to 1 year follow-up
|
|
|
Mortality
Time Frame: From surgery up to 1 year postoperative
|
From surgery up to 1 year postoperative
|
|
|
Muscle loss
Time Frame: From surgery up to 1 year follow-up
|
Calf circumference measurement comparison: Loss calculated in %
|
From surgery up to 1 year follow-up
|
|
Time to achieve partial and full weight bearing
Time Frame: From surgery to 1 year follow-up
|
Will be assessed during the patient interview
|
From surgery to 1 year follow-up
|
|
Duration of hospital stay
Time Frame: For the duration of hospital stay, an expected average of 3 weeks
|
For the duration of hospital stay, an expected average of 3 weeks
|
|
|
Numbers of re-admissions to the hospital
Time Frame: From surgery to 1 year follow-up
|
From surgery to 1 year follow-up
|
|
|
Quality of life: EuroQoL (EQ-5D)
Time Frame: 12 weeks postoperative
|
Quality of life questionnaire using the EQ-5D
|
12 weeks postoperative
|
|
Residential status
Time Frame: Baseline to 1 year follow-up
|
Will be assessed during the patient interview
|
Baseline to 1 year follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Frankie Leung, MD, Queen Mary Hospital, Hong Kong
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MobiChina
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fracture
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHip Fractures | Pathological Fracture | Pathological Fracture of Hip | Hip Fracture PathologicUnited States
-
JointResearchActive, not recruitingHip Fracture | Hip Fracture SurgeriesNetherlands
-
Sakarya UniversityNot yet recruitingHip Fracture SurgeriesTurkey
-
NYU Langone HealthRecruiting
-
University Health Network, TorontoRecruitingSurgery | Hip-fractureCanada
-
Lund UniversityMalmo Municipality, SwedenRecruiting
-
Hvidovre University HospitalCompleted
-
Michal Roll PhD,MBATel-Aviv Sourasky Medical CenterUnknown
-
Guy's and St Thomas' NHS Foundation TrustCompletedHip Fractures | Fracture of Hip | Fractured HipUnited Kingdom